Antibiotics against Pseudomonas aeruginosa for COPD exacerbation in ICU: a 10-year retrospective study - Wikidata - awgldk - TriplyDB

Antibiotics against Pseudomonas aeruginosa for COPD exacerbation in ICU: a 10-year retrospective study

Antibiotics against Pseudomonas aeruginosa for COPD exacerbation in ICU: a 10-year retrospective study

http://www.wikidata.org/entity/Q35110953

about

ATS Core Curriculum 2016: Part II. Adult Critical Care Medicine.Killing of P. aeruginosa by chicken cathelicidin-2 is immunogenically silent, preventing lung inflammation in vivo.

P2860

Q33772360-2F14CDE5-572A-420A-A643-C37EFCF165B1 Q41994275-D5DFB6FF-18E1-486E-A8AA-FD166448D05B

P2860

Antibiotics against Pseudomonas aeruginosa for COPD exacerbation in ICU: a 10-year retrospective study

http://www.wikidata.org/entity/Q35110953

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Antibiotics against Pseudomona ...... a 10-year retrospective study

@ast

Antibiotics against Pseudomona ...... a 10-year retrospective study

@en

type

label

Antibiotics against Pseudomona ...... a 10-year retrospective study

@ast

Antibiotics against Pseudomona ...... a 10-year retrospective study

@en

prefLabel

Antibiotics against Pseudomona ...... a 10-year retrospective study

@ast

Antibiotics against Pseudomona ...... a 10-year retrospective study

@en

P1433

Q35110953-BF04F81C-0266-4DA6-A32F-5F4C587614E2

P1476

Q35110953-1F72D905-32F8-4B6D-8920-8B015E5B4FD1

P2093

Q35110953-63E59C58-EB73-46B6-8E2B-1A33DF186725

Q35110953-74771664-D518-4318-98C4-A8D1AD698EC3

Q35110953-88A716EB-3300-43ED-B6D6-41B769381D85

Q35110953-8916AF50-A3DA-4389-BCC8-3D462B261996

Q35110953-92BCB116-3E27-464A-922D-DBEB13364317

Q35110953-987FC871-AE98-4EEA-AD38-2AACD2E502F8

Q35110953-AF842576-A9FA-40A7-9B80-75FCE49B4427

Q35110953-B75E2A0E-9D7D-4A19-9084-90C24D5B13B7

Q35110953-EE804787-F367-4408-9697-400F35251390

P2860

Q35110953-07646DF3-15B1-4360-975E-D7E323B0F1A9

Q35110953-1D8F91BC-BAD8-45D3-92B0-0C0FD85558E7

Q35110953-2A994737-B263-4BC9-A2D0-9BBBE5B5610E

Q35110953-427810D9-F141-43E6-A6DB-651FF97ECC02

Q35110953-4D67DE95-3BC2-428E-BDFD-43BF63AC0B8A

Q35110953-4D71FB4A-E73D-49FC-A3B4-AEDE70110700

Q35110953-78034BFE-8AD0-45A2-A408-B877EDF5F947

Q35110953-82C0BBA3-C1F5-44D0-9DED-47088366414E

Q35110953-8EC2BB21-A6ED-429C-BF9B-F228DE6CDD66

Q35110953-911AE4C1-AAC7-4B74-8203-929F182A4290

P304

Q35110953-EBD15427-4193-4808-BB5A-6460994CF2E7

P31

Q35110953-16AD190F-C19A-49E3-8B7A-C7DBCA56CF1C

P356

Q35110953-E4CBAC41-400B-41A2-9F94-6C2B8E37FEAB

P407

Q35110953-ABEC2A36-71A7-4196-9B0F-45D227643025

P478

Q35110953-0B8BA233-9041-4DD9-B9E0-68244C6EDCB6

P50

Q35110953-BF4B2A97-EBA8-427F-A404-8DDA453E31D2

Q35110953-EDB4DA0B-DA7A-4839-A486-18B0D0CAF714

P577

Q35110953-8C73B098-48E9-43A9-B67F-38A9AFFAF5F0

P698

Q35110953-C6DDB214-3CBC-4AE2-A3EE-65E5141E7CE0

P921

Q35110953-30CA0BC2-9502-46DE-8FF6-AF649283AEFB

Q35110953-9B7B06C6-A141-4517-802A-74040DFD3936

P932

Q35110953-EF5D3780-BC8D-4D40-9CA2-1DFDC27F2862

P356

P1433

International Journal of Chronic Obstructive Pulmonary Disease

P1476

Antibiotics against Pseudomona ...... a 10-year retrospective study

@en

P2093

Alexis Ferre

http://www.w3.org/2001/XMLSchema#string

Ariane Roujansky

http://www.w3.org/2001/XMLSchema#string

Benjamin Planquette

http://www.w3.org/2001/XMLSchema#string

Etienne Dubuisson

http://www.w3.org/2001/XMLSchema#string

Fabrice Bruneel

http://www.w3.org/2001/XMLSchema#string

Jean P Bedos

http://www.w3.org/2001/XMLSchema#string

Julien Péron

http://www.w3.org/2001/XMLSchema#string

Peter G Chiles

http://www.w3.org/2001/XMLSchema#string

Virginie Laurent

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study.

Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.

Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial.

A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology.

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

Antibiotic management of suspected nosocomial ICU-acquired infection: does prolonged empiric therapy improve outcome?

Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit.

P304

379-388

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/COPD.S71413

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Alban Le Monnier

Stéphane Legriel

P577

2015-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25733827

http://www.w3.org/2001/XMLSchema#string

P921

Pseudomonas aeruginosa

P932

4337514

http://www.w3.org/2001/XMLSchema#string